Rite Aid Corporation (NYSE: RAD) today announced sales results for July.
For the four weeks ended July 28, 2012, same store sales increased 0.5 percent over the prior-year period. July front-end same store sales increased 1.2 percent. Pharmacy same store sales, which included an approximate 742 basis points negative impact from new generic introductions increased 0.2 percent. Prescription count at comparable stores increased 4.5 percent over the prior-year period.
Total drugstore sales for the four-week period decreased 0.1 percent to $1.881 billion compared to $1.883 billion for the same period last year. Prescription sales accounted for 67.5 percent of drugstore sales, and third party prescription sales represented 96.4 percent of pharmacy sales.Year-to-Date Sales Same store sales for the 21-week period ended July 28, 2012 increased 1.5 percent over the prior-year period. Front-end same store sales increased 2.0 percent while pharmacy same store sales increased 1.2 percent. Prescription count at comparable stores increased 3.2 percent over the prior-year period. Total drugstore sales for the 21 weeks ended July 28, 2012 increased 0.8 percent with sales of $10.247 billion compared to $10.167 billion for the same period last year. Prescription sales represented 68.1 percent of total drugstore sales, and third party prescription sales represented 96.6 percent of pharmacy sales. Rite Aid is one of the nation’s largest drugstore chains. On July 28, 2012, the company operated 4,646 stores compared to 4,702 stores in the like period a year ago. Information about Rite Aid, including corporate background and press releases, is available through the company’s website at http://www.riteaid.com. Note that all sales data in this release is preliminary, unaudited and subject to revision. Statements in this release that are not historical are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are not guarantees of future performance and involve risks, assumptions and uncertainties that are described in Item 1A (Risk Factors) of our most recent Annual Report on Form 10-K and in other documents that we file or furnish with the Securities and Exchange Commission, which you are encouraged to read. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. Accordingly, you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they are made. Rite Aid expressly disclaims any current intention to update publicly any forward-looking statement after the distribution of this release, whether as a result of new information, future events, changes in assumptions or otherwise.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts